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M a n u s c r i p t 8 antibody technique and 6% polyethylene glycol (Serva, Heidelberg, Germany). The intra-1 assay variations were below 6% and the inter-assay variations below 14%. The ED 50 of the 2 assay was 0.6 ng/ml. Dilution of samples containing VEGF from blood plasma, follicular 3 fluid and tissue extracts ran parallel to the standard curve. The average recovery of exogenous 4 VEGF was 93-95%. 5 6 2.5 Reverse transcription and Real-Time PCR 7 Total RNA was prepared using Total RNA Prep Plus kit (A&A Biotechnology, 8
Gdansk, Poland) according to the manufacturer's instructions. Constant amounts of 2 µg of 9 total RNA were treated with DNase I (Invitrogen Life Technologies, Inc., Carlsbad, CA, 10 USA) as described in supplier's protocol. The RT reaction was carried out according to the 11 protocol detailed previously (Kaczmarek et al., 2007) . RT products were diluted fourfold in 12 sterile water and stored at -20°C until Real time PCR amplification. 13
Real time PCR was performed with an ABI Prism 7300 sequence detection system 14 using SYBR green PCR master mix (Applied Biosystems, Foster City, CA, USA) as 15 described elsewhere (Kaczmarek et al., 2007 , Kowalczyk et al., 2008 . Table 1 shows the 16 oligonucleotide primers used for PCR amplification of VEGF, VEGF164, VEGF120, VEGFR-17 1, VEGFR-2 and β-actin genes and expected product sizes. Serial dilutions of the appropriate 18 DNA were used as standard curves. The following general PCR conditions were used: 19 denaturation for 10 min at 95°C, followed by 35 cycles of 15 sec at 95°C and 1 min at 59°C 20 (for VEGFR-1) or 60°C (for VEGF, VEGF 164, VEGF 120, VEGFR-2, and β-actin). Melting 21 curves were obtained after each PCR reaction. The reactions were also run either on blank-22 only buffer samples or in absence of the reverse transcriptase. The specificity of RT/PCR 23 products was confirmed by gel electrophoresis and sequencing. Data obtained from the Real 24 Page 9 of 38 A c c e p t e d M a n u s c r i p t 9 time PCR for VEGF, VEGF164, VEGF120, VEGFR-1 and VEGFR-2 were normalized on the 1 basis of β-actin mRNA content. 2 3 2.6 Endothelial cell proliferation assay 4
A colorimetric assay was used for quantification of cell proliferation, based on 5 chemical reduction of growth indicator alamarBlue™ (Serotec Ltd., Oxford, UK). Human 6 umbilical vein endothelial cells (HUVEC) at passage one to four were allowed to adhere and 7 spread on 96-well dishes for 18 h (1x10 4 cells/well) in 10% NCS MCDB 131 supplemented 8 with antibiotics (100 IU/ml penicillin, 100 µg/ml streptomycin). Cells were first pretreated 9 with or without soluble VEGFR-1 or VEGFR-2 (100 ng/ml; sVEGFR-1, sVEGFR-2; Abcam, 10 Cambridge, UK) in MCDB 131 for 40 min. Afterwards, 35% of conditioned medium 11 collected during VEGF secretion studies (24 or 48 h treatment with IGF or RLX, selected in 12 preliminary experiments) in 2% NCS MCDB 131, alone or in combination with 100 ng/ml 13 sVEGFR-1 or sVEGFR-2 was added to each well in duplicates and incubated for 3 days. 14 VEGF (10 ng/ml; PeproTech EC Ltd., London, UK) was used as positive control. 15
Conditioned media were then replaced by fresh MCDB 131 containing 10% of alamarBlue™ 16 reagent and incubated for 7 h. Absorbance was measured at 570 and 595 nm and cell 17 proliferation equal to reduction of alamarBlue™ reagent was calculated according to the 18 supplier's manual. The plating density for HUVEC and length of incubation time with 19 alamarBlue™ was determined in preliminary experiments, as suggested by the supplier. 20 21
Statistical analysis 22
The data are expressed as mean ± S.E.M. of values obtained in three to seven 23 experiments (pigs), each performed in duplicate. Levels of VEGF were standardized on 24 protein concentration per well (pg/µg protein). Statistical analyses were conducted using one-M a n u s c r i p t 10 way ANOVA for repeated measurements followed by Dunnets's or Bonferroni's multiple 1 comparison post hoc tests (GraphPad PRISM v. 4.0, GraphPad Software, Inc., San Diego, 2 CA). Differences were considered to be statistically significant at P < 0.05. 3 4
Results 5

Immunofluorescent localization of VEGF in stromal cell culture 6
Immunostaining for VEGF was detectable in stromal cells, with characteristic 7 morphology, after 48 h of culture and was localized in the cytosol (Fig. 1A, B ). Negative 8 controls were consistently free from staining (Fig. 1C ). 9 10
Effect of IGF-I and RLX on VEGF secretion 11
Both, IGF-I and RLX stimulated VEGF secretion from endometrial stromal cells in 12 dose-and time-dependent manner (Fig. 2 ). Basal secretion of VEGF (pg/µg protein) increased 13 from 2.5 ± 0.4 (12 h) to 5.3 ± 0.6 (48 h). IGF-I-stimulated secretion of VEGF was detected 14 during all studied time-periods (12-48 h). Although, after 12 h only the highest dose of IGF-I 15 was effective (100 ng/ml; P < 0.05), longer incubation resulted in a significant enhance of 16 VEGF secretion from stromal cells at all tested doses (P < 0.01). The most effective action of 17 IGF-I was found after 48 h of incubation, when VEGF concentration in medium increased 18 1.8-fold for doses 10 and 100 ng/ml (8.1 ± 0.5 and 8.2 ± 0.6 vs 4.6 ± 0.4, respectively; P < 19 0.01). Effect of RLX on VEGF release was observed only after 24 and 48 h of incubation, 20 when two or all used doses significantly stimulated secretion of VEGF, respectively (P < 21 0.01). Long-term exposure (48 h) of stromal cells to 100 ng/ml RLX led to maximal 1.8-fold 22 increase of VEGF release (11.0 ± 1.7 vs 6.0 ± 1.1; P < 0.01). 23
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Effect of OT and PGE 2 on VEGF secretion 1
Release of VEGF from cultured stromal cells was affected by both dose of OT or 2 PGE 2 and time of incubation ( Fig. 3 ). Basal secretion of VEGF (pg/µg protein) increased 3 from 1.9 ± 0.4 (6 h) to 4.6 ± 0.2 (48 h). Although, OT seemed to inhibit VEGF secretion 4 starting from 6 h of incubation, significant effect was detected only after 24 and 48 h, when 5 100 nM OT was used (3.4 ± 0.6 vs 4.0 ± 0.7, P < 0.05 and 3.4 ± 0.7 vs 4.9 ± 0.2, P < 0.01; 6 respectively). An augmentation of VEGF secretion by PGE 2 in stromal cells was detected as 7 early as 6 h, but exclusively for 1 µM PGE 2 (1.4-fold, P < 0.05). However, the most effective 8 action of PGE 2 was observed after 48 h of incubation, when amounts of VEGF released into 9 medium were induced approximately 1.3-fold for doses 0.1 and 1 µM (5.4 ± 0.5 and 5.8 ± 0.3 10 vs 4.4 ± 0.3, P < 0.05, P < 0.01; respectively). 11 12 
Effect of IGF-I and RLX on VEGF gene expression 13
The dose-dependent effect of IGF-I and RLX (for both 0-100 ng/ml) on VEGF, 14 VEGF164 and VEGF120 mRNA expression in stromal cells after 24 h of treatment is shown 15 on Figure 4 . The expression of VEGF, VEGF164 and VEGF120 mRNA was affected only by 16 50 and 100 ng/ml IGF-I (P < 0.05). The maximal, almost 2-fold increase of VEGF, VEGF164 17 and VEGF120 mRNA expression was observed when the highest dose of IGF-I was used 18 (100 ng/ml; P < 0.01, P < 0.05 and P < 0.05, respectively). Although VEGF and VEGF164 19 expression was induced by 50 and 100 ng/ml RLX (P < 0.05 and P < 0.01, respectively), 20 VEGF120 expression was significantly increased when the highest dose was used (P < 0.05). 21
The maximal stimulation of VEGF, VEGF164 and VEGF120 mRNA expression was found in 22 cells stimulated with 100 ng/ml RLX (1.6-, 1.8-and 1.5-fold; P < 0.01, P < 0.01, P < 0.05, 23 respectively). 24 M a n u s c r i p t 12 Figure 5 shows the dose-dependent effect of OT (0-100 nM) and PGE 2 (0-1 µM) on 2 VEGF, VEGF164 and VEGF120 mRNA expression in endometrial stromal cells after 24 h of 3 incubation. In OT-treated cells tendency to decreased expression of VEGF, VEGF164 and 4 VEGF120 mRNA was observed, however significant inhibition was only detected for dose 5 100 nM (P < 0.05). Although, stimulation of VEGF, VEGF164 mRNA expression by PGE 2 6 was dose-dependent, VEGF120 levels were maintained constant. The maximal induction (1.8-7 fold) was obtained with 1 µM PGE 2 for VEGF and 0.1 and 1 µM PGE 2 for VEGF164 (P < 8 0.05). 9 10 Table 2 shows the effect of IGF-I (0-100 ng/ml), RLX (0-100 ng/ml), OT (0-100 nM) 12
Effect of OT and PGE 2 on VEGF gene expression 1
Effect of IGF-I, RLX, OT and PGE 2 on VEGFRs gene expression 11
and PGE 2 (0-1 µM) on VEGFR-1 and VEGFR-2 expression in endometrial stromal cells after 13 24 h of incubation. Both receptors mRNA expression in cells incubated with various 14 concentrations of IGF-I, RLX, OT or PGE 2 was not affected by the treatment. 15 16 
Endothelial cell proliferation assay 17
The ability of media conditioned by porcine endometrial stromal cells after IGF-I or 18
RLX treatment to affect HUVEC proliferation is shown on Figure 6 . Both IGF-I and RLX 19 conditioned media increased HUVEC proliferation (P < 0.001 and P < 0.01; respectively). 20
The effect was comparable to the level of proliferation observed for the positive control (45.6 21 Several studies, using different animal models, have shown that periimplantation 5 period is critical for embryo implantation, pregnancy success as well as the future growth and 6 developmental potential of embryos. Since VEGF regulates periimplantation vascular 7 permeability in rodents (Rabbani and Rogers, 2001 ) and female mice treated with VEGF 8 antiserum on day 4 after mating (the normal day of implantation) fail to deliver any pups 9 (Rockwell et al., 2002) it is tempting to believe that VEGF is one of the factors of uterine 10 periimplantation environment being crucial for pregnancy success. Recent results have 11 indicated upregulation of VEGF164 protein in endometrium in the periimplantation period in 12 pigs that agrees with patterns of estradiol secretion by the conceptus (Kaczmarek et al, 2008) . showed that stroma population collected on days 11-13 of pregnancy may produce more M a n u s c r i p t 14 PGE 2 than PGF 2α (Zhang and Davis, 1991) . The close proximity of stromal cells to the uterine 1 vascular bed also predestinates them to be the main source of factors regulating 2 vascularization and vessel permeability, such as VEGF. Recently, we have demonstrated that 3 uterine stroma may be an important source of VEGF during early pregnancy in pigs 4 (Kaczmarek et al, 2008) . Furthermore, results of the present immunoflourescent staining 5 showed that after 48 h-long culture stromal cells were not deprived of VEGF expression. 6
During the periimplantation period, the porcine uterine endometrium and conceptuses 7 exhibit dramatic biochemical, structural and morphological changes (Geisert et al, 1982) . King, 1988). PGE 2 has been shown to upregulate VEGF in a number of tissues; however there 1 is only one report demonstrating transcriptional regulation of VEGF gene expression in the 2 uterus (Lopes et al., 2006) . Interestingly, we found PGE 2 to significantly increase VEGF164 3 mRNA levels in porcine endometrial stromal cells, whereas VEGF120 and VEGFR mRNA 4 was not affected by the treatment. Halder et al. (2000) showed that VEGF164 is one of the 5 primary mediators of VEGF signaling in the uterine vascular changes during implantation in 6 mice. Thus, it appears that PGE 2 may be involved in induction of vascular permeability 7 during implantation time in the pig, by improving VEGF164 secretion from endometrial 8 stroma. 9
The presence of a low concentration of OTR in the endometrium during early 10 pregnancy (Okano et al., 1996) at first suggested that OT, known inducer of uterine PGF 2α 11 secretion, is involved in the process of maternal recognition of pregnancy in pigs (Carnahan et  12 al., 1996; Edgerton et al., 1996) . Further demonstration that endometrial sensitivity to OT is 13 not regulated primarily through changes in OTR population density (Ludwig et al., 1998) have also some effects on receptors in intact tissue if they are produced in stromal cells. 8 VEGF may act therefore directly on endothelial cells and also as a chemokine in attracting 9 endothelial cell migration during the outgrowth of new vessels in the endometrium. 10
In the present study, proliferation of HUVEC in vitro was induced directly by media 11 conditioned by stromal cells collected after IGF-I and RLX treatment. These effects were 12 blocked by sVEGFR-1, suggesting that IGF-I-and RLX-stimulated VEGF is able to induce 13 endothelial cells proliferation. More significant inhibition of HUVEC proliferation by media 14 conditioned by stromal cells collected after RLX treatment, may have an explanation in our 15 gene expression studies, where levels of highly mitogenic VEGF164 mRNA were induced by 16 RLX in a grater manner comparing to IGF-I. In contrast, sVEGFR-2 (no naturally occurring 17 splice variant) was not able to significantly inhibit HUVEC proliferation; however such a 18 tendency was observed. Like other growth factor transmembrane tyrosine kinase receptors, 19 VEGF receptors presumably undergo ligand-induced dimerization to activate transduction 20 pathways. Thus, dimers between sVEGFR and full-length VEGF receptor block signal 21 pathways dependent on intracellular tyrosine kinase dimerization. Both soluble receptors used 22
in the experiment has the same ED 50 for VEGF-dependent proliferation of HUVEC provided 23 by the supplier (10-30 ng/ml), therefore the reason of such observation in a present study may 24 rather not lay in a dose of the sVEGFR used in a culture. However, previous results showed In summary, the present study is the first to demonstrate that VEGF-receptor system 6 expression in porcine endometrial stromal cells is controlled by factors creating a unique 7 microenvironment for successful embryo implantation in pigs. IGF-I and RLX are the most 8 potent inducers of VEGF secretion and mRNA expression, acting together with estrogens of 9 embryonic origin. Luteoprotective PGE 2 was effective in stimulation of VEGF secretion as 10 well as VEGF164 mRNA expression suggesting its participation in vascular events during 11 implantation. In contrast, high doses of OT seem to inhibit VEGF-mediated actions in 12 endometrial stroma during early pregnancy in pigs. These results suggest that during the 
